与同仁堂科技“零距离”沟通 投资者感受老字号新动能

Core Viewpoint - The investor research event held by Tong Ren Tang Technology showcased the company's commitment to modernizing traditional Chinese medicine while maintaining its heritage and quality standards [1][2]. Group 1: Production and Innovation - The production line at Tong Ren Tang Technology employs automated and connected processes, ensuring efficiency and quality in the manufacturing of traditional Chinese medicine products [2]. - The company is focused on upgrading its production capabilities and implementing new technologies to create a modern intelligent manufacturing system for traditional Chinese medicine [2]. - The goal is to ensure that every pill produced meets high-quality standards and is traceable, embodying the spirit of Tong Ren Tang in a modern factory setting [2]. Group 2: Management Communication and Strategy - During the event, the management team, led by General Manager Zhang Chunyou, engaged in detailed discussions with investors regarding the company's operational strategy, product positioning, and future growth opportunities [3]. - The management emphasized the systemic development opportunities in the traditional Chinese medicine industry, driven by national health strategies and policies [3]. - Tong Ren Tang Technology aims to leverage its brand, technology, and quality advantages to deepen its focus on traditional Chinese medicine and explore new growth avenues in health management [3]. Group 3: Investor Relations - The research event served as a platform for enhancing investor relations, with the management team expressing the importance of transparent communication with investors [4]. - The company is committed to maintaining an open and inclusive investor relations ecosystem, reflecting its strategic determination and proactive approach in the industry [4]. - Continuous and transparent communication is seen as a vital bridge connecting the company with long-term value investors [4].